Praxis Precision Medicines Updates Corporate Progress
19 Feb 2026 //
GLOBENEWSWIRE
Praxis Precision Pharma Advances After A Key Year Of Achievements
12 Jan 2026 //
GLOBENEWSWIRE
Praxis Precision Medicines To Submit NDA For Relutrigine
11 Dec 2025 //
GLOBENEWSWIRE
Praxis Leads in Rare Pediatric & Adult Epilepsies at AES
08 Dec 2025 //
GLOBENEWSWIRE
Praxis Precision Medicines Reports Positive EMBOLD Study Results
04 Dec 2025 //
GLOBENEWSWIRE
Praxis Gets Accelerated Path for Relutrigine in SCN2A & SCN8A DEE
04 Nov 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support